 |
Sufentanil

Introduction
Efficacy
Safety
Prescribing Information
FAQs
History
Related Links
|
History
History of Sufentanil in China - In March 2002, clinical trials for registration in China were completed. (Collaborators: Beijing PUMC Hospital, Peking University First Hospital, Beijing Chao-Yang Hospital). Sufentanil was launched the following year in 2003, and was included in national medical insurance in 2004.
- From 2004 through 2006, national multicenter clinical studies regarding the use of Sufentanil in cardiovascular surgery and labor analgesia were completed. With over 3,000 cases studied during this period, the safety and efficacy of Sufentanil were well established.
- Between 2004 and 2007, more than 600 articles related to Sufentanil were published in a wide range of journals and magazines. These included over 80 articles published in The Chinese Journal of Anesthesiology, the most respected Chinese journal on anesthesia and analgesia.
- During 2005-2007, PUMC Pharmaceutical, in cooperation with the editorial board of The Chinese Journal of Anesthesiology, successfully sponsored two national paper competitions regarding clinical applications of Sufentanil. Roughly 200 articles were submitted, 42 of which were subsequently published in Chinese Journal of Anesthesiology. Ceremonies for the 2006 and 2007 First Prize winners were held in Qingdao and Beijing, respectively.
- In July 2008, collected papers from the above competitions were published by PUMC Pharmaceutical, with an introduction written by Professor Luo Ailun, a leading anesthesiologist and editor-in-chief of The Chinese Journal of Anesthesiology.
< Previous | Next >
|
 |